Raymond James Financial Inc. Purchases Shares of 233,657 Pediatrix Medical Group, Inc. (NYSE:MD)

Raymond James Financial Inc. acquired a new position in Pediatrix Medical Group, Inc. (NYSE:MD) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 233,657 shares of the company’s stock, valued at approximately $3,066,000. Raymond James Financial Inc. owned about 0.27% of Pediatrix Medical Group as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in the stock. Renaissance Technologies LLC boosted its position in Pediatrix Medical Group by 117.4% in the 4th quarter. Renaissance Technologies LLC now owns 838,800 shares of the company’s stock valued at $11,005,000 after buying an additional 453,000 shares during the period. Legal & General Group Plc boosted its stake in shares of Pediatrix Medical Group by 2.2% in the 4th quarter. Legal & General Group Plc now owns 238,935 shares of the company’s stock valued at $3,135,000 after buying an additional 5,033 shares during the period. Wells Fargo & Company MN grew its position in shares of Pediatrix Medical Group by 11.0% during the fourth quarter. Wells Fargo & Company MN now owns 66,028 shares of the company’s stock worth $866,000 after buying an additional 6,521 shares in the last quarter. Trexquant Investment LP raised its holdings in Pediatrix Medical Group by 112.0% in the fourth quarter. Trexquant Investment LP now owns 431,230 shares of the company’s stock valued at $5,658,000 after acquiring an additional 227,825 shares in the last quarter. Finally, Geode Capital Management LLC lifted its stake in Pediatrix Medical Group by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 1,947,796 shares of the company’s stock worth $25,562,000 after acquiring an additional 11,045 shares during the last quarter. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on MD shares. StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. UBS Group upped their price objective on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research note on Friday, February 21st. Finally, Truist Financial reduced their target price on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating for the company in a research note on Friday, April 11th. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $16.75.

Pediatrix Medical Group Stock Up 0.9 %

Pediatrix Medical Group stock opened at $12.36 on Tuesday. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60. The stock’s fifty day moving average is $14.01 and its two-hundred day moving average is $13.99. The firm has a market capitalization of $1.06 billion, a price-to-earnings ratio of -10.30, a price-to-earnings-growth ratio of 1.74 and a beta of 1.32.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The company had revenue of $502.36 million during the quarter, compared to analysts’ expectations of $486.22 million. Analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.